Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03930576
Other study ID # 18-25863
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date April 16, 2019
Est. completion date December 15, 2028

Study information

Verified date June 2024
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this project is to examine the health consequences of unwanted pregnancy and denial of legal pregnancy termination services in Nepal on women and their children. The proposed study will be a large, longitudinal, prospective, quantitative study among women seeking termination services at 14 diverse facilities in 7 provinces (two facilities in each province) of Nepal. Every 6 months following baseline, surveys will cover questions about women's physical and mental health, the health and development of their children, as well as measures of family wellbeing, such as residency, relationship status and quality, and extended family relationships, and financial wellbeing, such as employment status, hours of labor, food security, income, and education.


Description:

The objective of this project is to examine the health consequences of unwanted pregnancy and denial of legal pregnancy termination services in Nepal on women and their children. Births following unwanted pregnancies can be associated with negative physical, social and economic consequences for both the woman and child. Half of all unintended pregnancies are terminated before they are carried to term and, when performed in unsafe or illegal conditions, the consequences can include infection, infertility, and death. The incidence of mortality and morbidity from abortion are notoriously difficult to measure. Widespread stigma associated with unwanted pregnancy - even in settings in which termination is legally available - contribute to misreporting, concealment, and misattribution of termination-related morbidity and mortality. In addition, many women seek illegal methods-both safe and unsafe-which further confounds efforts to measure the prevalence of mortality and morbidity from terminations. The effects of unwanted pregnancy on children, including children born prior to and subsequent to the unwanted pregnancy, are also not well established. A prospective longitudinal study of women with unwanted pregnancies is required to validly investigate the health consequences for women and their families of termination outside of the legal system and delivery of an unwanted pregnancy, as compared to legal termination. Such a study is only possible in places like Nepal, where termination is legal but barriers prevent some women from receiving the service. Aim 1: To investigate the predictors of denial of legal pregnancy termination services and identify groups of women who may be at elevated risk of adverse sequelae from unwanted pregnancy. Aim 2: To assess the health consequences for women of childbirth and illegal termination after denial of a legal termination. By comparing the two groups of women denied termination of pregnancy to those obtaining legal procedures, the study team will assess the health effects of denial while accounting for factors associated with experience of unwanted pregnancy. Aim 3: To measure the effects of legal and illegal termination compared to birth on the health and development of women's existing and subsequent children Prospective longitudinal data from women in a less developed country would provide valuable evidence for the development of programs and policies globally to improve access to and utilization of safe termination services where they are legal, and harm reduction services for women who are unable to access services.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1436
Est. completion date December 15, 2028
Est. primary completion date December 15, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years and older
Eligibility Inclusion Criteria: - women - seeking pregnancy termination services at one of the study facilities - self-report last menstrual period to be at least 10 weeks ago or not know her gestational age - 15 years old or older - live in Nepal Exclusion Criteria: - under 15 years old - not pregnant - do not live in Nepal

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Receipt of termination services outside of legal setting
This study uses variation in gestational age to examine the impact of receipt of legal termination services compared to denial and receipt outside legal settings and birth.

Locations

Country Name City State
Nepal CREHPA Kathmandu

Sponsors (2)

Lead Sponsor Collaborator
University of California, San Francisco Center for Research on Environment Health and Population Activities (CREHPA)

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion experiencing denial of termination services on day of recruitment This will be defined as the proportion of participants who did not receive termination services on the day they were recruited at the clinic site where they are recruited in to the study. 6 weeks
Primary Proportion of participants who did not receive a termination from an approved facility Proportion of participants who did not receive termination services from the recruitment clinic and did not receive a termination at any facility that they were referred to by the recruitment facility 6 weeks
Primary Proportion of termination-seeking participants who received a termination Participants will report their pregnancy outcome at 6 months; the proportion of participants who had an abortion by 6 months versus had a miscarriage, gave birth, or were still pregnant. 6 months
Primary Proportion of existing children with stunting at 36 months The proportion of children existing at the time of termination-seeking who having stunting, or low height-for-age, defined according to the World Health Organization as less than two standard deviations of the World Health Organization Child Growth Standards median. 36 months
Primary Maternal deaths during the study period Proportion of maternal deaths by end of study. The study team will implement a verbal autopsy protocol for any women who die during the study period, with a particular focus on identifying specific pregnancy-related causes of death. 36 months
Primary Proportion of women reporting poor health by 36 months The proportion of participants who self-report poor or very poor physical health by 36 months. 36 months
Primary Proportion of subsequent children with stunting The proportion of subsequent children born to participants after the index pregnancy who having stunting, or low height-for-age, defined according to the World Health Organization as less than two standard deviations of the World Health Organization Child Growth Standards median. 36 months
Secondary Proportion experiencing violence from husband at each year of follow up Proportion experiencing any physical violence from husband over time (12 months, 24 months, 36 months), defined pushed you, shake you, throw something at you (yes/no), slapped you (yes/no), twisted your arm or pulled your hair (yes/no), punched you (yes/no), kicked you (yes/no), tried to choke you (yes/no), threatened or attacked you with a weapon (yes/no). 36 months
Secondary Proportion experiencing violence from any family members or close relatives other than husband at 36 months Self-reported violence from family members or close relatives other than husband or partner (yes/no) in the past 12 months. 36 months
Secondary Proportion reporting depression at 36 months Proportion of participants self-reporting feeling down, depressed or hopeless nearly every day, more than half the days, or several days in the prior two weeks. 36 months
See also
  Status Clinical Trial Phase
Completed NCT03600857 - Medical Termination of II Trimester Pregnancy Phase 4